Artia Global Partners LP
Filing Date
Global Rank
#2,781
/ 8,700
▲ 764
Top Industry
Biotechnology
77.5%
Period ended 2 months ago
Filed Aug 14, 2026 · 29d
15 quarters · since Dec 2022
Portfolio Concentration
47 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026Top Position
13.1%
−17.1 pts
Top 5
46.4%
−14.0 pts
Top 10
66.6%
−8.4 pts
HHI
598
Diversified−668
Portfolio Trend
15 quarters · across all stocks
Sector Breakdown
As of Jun 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $525,427,661 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
11 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| BTSG | BrightSpring Health Services, Inc. | +463,515 | 517,315 | $36,077,548 | |
| TVTX | Travere Therapeutics, Inc. | +268,333 | 339,033 | $19,260,464 | |
| TRVI | Trevi Therapeutics, Inc. | +197,250 | 2,210,852 | $41,232,389 | |
| RVMD | Revolution Medicines, Inc. | +60,400 | 185,390 | $34,719,839 | |
| CYTK | Cytokinetics Inc | +54,400 | 70,700 | $6,022,933 | |
| ELVN | Enliven Therapeutics, Inc. | +51,200 | 72,100 | $3,659,075 | |
| CELC | Celcuity Inc. | +43,740 | 59,316 | $6,205,639 | |
| EWTX | Edgewise Therapeutics, Inc. | +33,300 | 98,800 | $4,014,244 | |
| DGX | Quest Diagnostics Inc | +24,305 | 65,122 | $13,802,607 | |
| AZN | Astrazeneca PLC | +3,000 | 98,376 | $18,654,057 | |
| PTGX | Protagonist Therapeutics, Inc | +20 | 22,951 | $2,813,333 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
6 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| ALKS | Alkermes plc. | 448,964 | $23,525,713 | |
| GH | Guardant Health, Inc. | 38,100 | $5,716,143 | |
| ABSI | Absci Corp | 464,444 | $5,382,905 | |
| ORKA | Oruka Therapeutics, Inc. | 33,400 | $3,178,678 | |
| CMPX | Compass Therapeutics, Inc. | 383,200 | $839,208 | |
| SYRE | Spyre Therapeutics, Inc. | 4,000 | $355,120 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
8 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| LLY | ELI LILLY & Co | 38,220 | $35,153,609 | |
| MRNA | Moderna, Inc. | 200,000 | $10,160,000 | |
| ABBV | AbbVie Inc. | 14,500 | $3,153,605 | |
| BBIO | BridgeBio Pharma, Inc. | 20,400 | $1,514,904 | |
| APGE | Apogee Therapeutics, Inc. | 5,886 | $495,424 | |
| AVTX | Avalo Therapeutics, Inc. | 28,970 | $432,522 | |
| — | 68,490 | $0 | ||
| — | 104,800 | $0 | ||
| No positions match the current search. | ||||
47 tracked positions ·
$525,427,661 total
· filing declares
48 positions · $541,855,576
· as of Jun 30, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| ABVX |
Abivax S.A.
Healthcare
|
Reduced | 516,447 | $68,821,727 | 13.10% | |
| INSM |
INSMED Inc
Healthcare
|
Reduced | 589,052 | $62,804,724 | 11.95% | |
| TRVI |
Trevi Therapeutics, Inc.
Healthcare
|
Added | 2,210,852 | $41,232,389 | 7.85% | |
| BTSG |
BrightSpring Health Services, Inc.
Healthcare
|
Added | 517,315 | $36,077,548 | 6.87% | |
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
Added | 185,390 | $34,719,839 | 6.61% | |
| ARGX |
Argenx SE
Healthcare
|
Held | 29,739 | $27,590,952 | 5.25% | |
| ALKS |
Alkermes plc.
Healthcare
|
NEW | 448,964 | $23,525,713 | 4.48% | |
| TVTX |
Travere Therapeutics, Inc.
Healthcare
|
Added | 339,033 | $19,260,464 | 3.67% | |
| AZN |
Astrazeneca PLC
Healthcare
|
Added | 98,376 | $18,654,057 | 3.55% | |
| NAMS |
NewAmsterdam Pharma Co N.V.
Healthcare
|
Held | 503,936 | $17,078,391 | 3.25% | |
| DNTH |
Dianthus Therapeutics, Inc. /DE/
Healthcare
|
Held | 162,990 | $15,888,265 | 3.02% | |
| DGX |
Quest Diagnostics Inc
Healthcare
|
Added | 65,122 | $13,802,607 | 2.63% | |
| IONS |
Ionis Pharmaceuticals Inc
Healthcare
|
Held | 144,376 | $11,447,573 | 2.18% | |
| EYPT |
EyePoint, Inc.
Healthcare
|
Held | 767,098 | $10,969,501 | 2.09% | |
| ALMS |
Alumis Inc.
Healthcare
|
Reduced | 278,546 | $7,838,284 | 1.49% | |
| VKTX |
Viking Therapeutics, Inc.
Healthcare
|
Held | 180,731 | $7,050,316 | 1.34% | |
| CELC |
Celcuity Inc.
Healthcare
|
Added | 59,316 | $6,205,639 | 1.18% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
Added | 70,700 | $6,022,933 | 1.15% | |
| MRK |
Merck & Co., Inc.
Healthcare
|
Held | 46,700 | $6,000,950 | 1.14% | |
| RAPP |
Rapport Therapeutics, Inc.
Healthcare
|
Held | 138,508 | $5,771,628 | 1.10% | |
| JNJ |
Johnson & Johnson
Healthcare
|
Held | 22,600 | $5,739,722 | 1.09% | |
| GH |
Guardant Health, Inc.
Healthcare
|
NEW | 38,100 | $5,716,143 | 1.09% | |
| ABSI |
Absci Corp
Healthcare
|
NEW | 464,444 | $5,382,905 | 1.02% | |
| SRRK |
Scholar Rock Holding Corp
Healthcare
|
Held | 96,285 | $5,295,675 | 1.01% | |
| SION |
Sionna Therapeutics, Inc.
Healthcare
|
Held | 119,741 | $5,267,406 | 1.00% | |
| ASND |
Ascendis Pharma A/S
Healthcare
|
Held | 17,740 | $4,731,612 | 0.90% | |
| ROIV |
Roivant Sciences Ltd.
Healthcare
|
Held | 129,800 | $4,593,622 | 0.87% | |
| PALI |
Palisade Bio, Inc.
Healthcare
|
Held | 1,992,367 | $4,164,047 | 0.79% | |
| EWTX |
Edgewise Therapeutics, Inc.
Healthcare
|
Added | 98,800 | $4,014,244 | 0.76% | |
| BIIB |
Biogen Inc.
Healthcare
|
Held | 18,437 | $3,983,498 | 0.76% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
Held | 65,000 | $3,923,400 | 0.75% | |
| BLTE |
Belite Bio, Inc
Healthcare
|
Held | 24,989 | $3,847,931 | 0.73% | |
| MLYS |
Mineralys Therapeutics, Inc.
Healthcare
|
Held | 137,800 | $3,717,844 | 0.71% | |
| PROK |
Prokidney Corp.
Healthcare
|
Held | 1,806,939 | $3,686,155 | 0.70% | |
| ELVN |
Enliven Therapeutics, Inc.
Healthcare
|
Added | 72,100 | $3,659,075 | 0.70% | |
| ORKA |
Oruka Therapeutics, Inc.
Healthcare
|
NEW | 33,400 | $3,178,678 | 0.60% | |
| PTGX |
Protagonist Therapeutics, Inc
Healthcare
|
Added | 22,951 | $2,813,333 | 0.54% | |
| UTHR |
UNITED THERAPEUTICS Corp
Healthcare
|
Held | 5,000 | $2,709,150 | 0.52% | |
| DRUG |
Bright Minds Biosciences Inc.
Healthcare
|
Held | 38,407 | $2,696,171 | 0.51% | |
| KNSA |
Kiniksa Pharmaceuticals International, plc
Healthcare
|
Held | 29,200 | $1,867,340 | 0.36% | |
| CMPX |
Compass Therapeutics, Inc.
Healthcare
|
NEW | 383,200 | $839,208 | 0.16% | |
| PRAX |
Praxis Precision Medicines, Inc.
Healthcare
|
Held | 2,500 | $836,975 | 0.16% | |
| KOD |
Kodiak Sciences Inc.
Healthcare
|
Held | 17,019 | $663,060 | 0.13% | |
| TENX |
Tenax Therapeutics, Inc.
Healthcare
|
Held | 42,080 | $612,264 | 0.12% | |
| PEPG |
PepGen Inc.
Healthcare
|
Held | 205,324 | $369,583 | 0.07% | |
| SYRE |
Spyre Therapeutics, Inc.
Healthcare
|
NEW | 4,000 | $355,120 | 0.07% | |
|
|
Held | 4,900 | $0 | 0.00% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.